A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube.
about
Ovarian serous carcinoma: recent concepts on its origin and carcinogenesisCancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinomaRecent concepts of ovarian carcinogenesis: type I and type IIThe oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention"Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearanceA genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium.Fallopian tube origin of supposed ovarian high-grade serous carcinomas.Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells.Human ovarian cancer stroma contains luteinized theca cells harboring tumor suppressor gene GT198 mutationsEarly preinvasive lesions in ovarian cancer.Endosalpingiosis in peritoneal washings in women with benign gynecologic conditions: thirty-eight cases confirmed with paired box-8 immunohistochemical staining and correlation with surgical biopsy findings.The utility of immunohistochemistry for providing genetic information on tumors.High-grade serous carcinoma of tubo-ovarian origin: recent developments.Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.Fallopian tube as main source for ovarian and pelvic (non-endometrial) serous carcinomas.Müllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol.Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition.Comparison of the Classical Method and SEE-FIM Protocol in Detecting Microscopic Lesions in Fallopian Tubes with Gynecological Lesions.Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.A mouse model for endometrioid ovarian cancer arising from the distal oviduct.
P2860
Q26822545-F2A7C102-0D37-45F1-946F-5CDD6EB99EC5Q26998068-A77B001C-701F-46BF-9EEC-57E619BAC533Q27009487-42ABCD22-0403-4B46-8696-13E83E219ED1Q27025315-48293A2D-7676-4B77-A7C5-CCCF57659B31Q30579225-1DC3886C-C022-4A54-B532-F251CE48F1A3Q34111959-9328E829-8701-44C7-BE2F-3143E571C026Q34498581-C277CB27-FEA1-453F-9137-80A5A792875CQ34604042-DFB8FE60-E26D-473A-8DDC-B1D50C21E1FAQ35209384-5A53BF37-6F17-4419-99DD-9C2688B05640Q35897417-0A51E49F-1B62-43BB-8257-DE8EDE037C7AQ36004053-9F786889-D725-44C7-811D-16A312AB74BCQ36976183-6A65C6E9-CF54-4863-B3BC-80DB8FCCC9EBQ37311456-C96FD9D7-9D35-40E9-BB97-D8B4F5B25025Q37719090-DBC88FBE-EDA1-4154-BC6F-1A00B2BE5ACCQ38106920-EDCE2E79-E3F6-420F-88A6-5CE3F7E4F72DQ38142818-8F7B1DCC-E30D-4C4D-AFCB-B061ACCC5309Q38687061-0D830C3F-BB2E-4F22-B040-A6AE45421043Q38978839-086B2290-0C1A-4896-8CB4-A8DD7E1102BBQ43158887-EE1B4E5C-63EF-431D-83B0-812A718C0450Q43703057-0F537E5B-44DE-41CF-9FD7-BE784ADE4EC8Q48127388-1ADE19F4-7EF1-40C8-9E9A-F4E5E23AA203Q49184692-53D21B50-B74D-44D0-8540-44AA0BB7F262Q53140410-74701379-9623-46F3-B407-415CFB4B3A48Q54296090-56CD70AC-775E-4C95-BA89-428B93365E1B
P2860
A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A pathologist's road map to be ...... rations in the fallopian tube.
@en
A pathologist's road map to be ...... rations in the fallopian tube.
@nl
type
label
A pathologist's road map to be ...... rations in the fallopian tube.
@en
A pathologist's road map to be ...... rations in the fallopian tube.
@nl
prefLabel
A pathologist's road map to be ...... rations in the fallopian tube.
@en
A pathologist's road map to be ...... rations in the fallopian tube.
@nl
P2093
P1476
A pathologist's road map to be ...... rations in the fallopian tube.
@en
P2093
Christopher Paul Crum
Eleanor Y Chen
Karishma K Mehra
Mitra Mehrad
P304
P356
10.1097/PAP.0B013E3181ECDEE1
P577
2010-09-01T00:00:00Z